| 000 | 02506 a2200625 4500 | ||
|---|---|---|---|
| 005 | 20250514053238.0 | ||
| 264 | 0 | _c20030731 | |
| 008 | 200307s 0 0 eng d | ||
| 022 | _a0268-3369 | ||
| 024 | 7 |
_a10.1038/sj.bmt.1703760 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aWernstedt, P | |
| 245 | 0 | 0 |
_aFavorable outcome with STI571 (imatinib mesylate) and allogeneic stem cell transplantation in a case of Ph+ chemorefractory acute lymphocytic leukaemia. _h[electronic resource] |
| 260 |
_bBone marrow transplantation _cDec 2002 |
||
| 300 |
_a971-3 p. _bdigital |
||
| 500 | _aPublication Type: Case Reports; Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAmsacrine _xadministration & dosage |
| 650 | 0 | 4 |
_aAntineoplastic Agents _xtherapeutic use |
| 650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xadministration & dosage |
| 650 | 0 | 4 | _aBenzamides |
| 650 | 0 | 4 |
_aBetamethasone _xadministration & dosage |
| 650 | 0 | 4 |
_aBiomarkers, Tumor _xgenetics |
| 650 | 0 | 4 | _aCombined Modality Therapy |
| 650 | 0 | 4 |
_aCyclophosphamide _xadministration & dosage |
| 650 | 0 | 4 |
_aCytarabine _xadministration & dosage |
| 650 | 0 | 4 |
_aDaunorubicin _xadministration & dosage |
| 650 | 0 | 4 | _aDrug Resistance, Neoplasm |
| 650 | 0 | 4 |
_aEnzyme Inhibitors _xtherapeutic use |
| 650 | 0 | 4 |
_aEtoposide _xadministration & dosage |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aFusion Proteins, bcr-abl _xgenetics |
| 650 | 0 | 4 |
_aGraft vs Host Disease _xdrug therapy |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aImatinib Mesylate |
| 650 | 0 | 4 |
_aImmunosuppressive Agents _xtherapeutic use |
| 650 | 0 | 4 |
_aMitoxantrone _xadministration & dosage |
| 650 | 0 | 4 | _aNeoplasm, Residual |
| 650 | 0 | 4 | _aPeripheral Blood Stem Cell Transplantation |
| 650 | 0 | 4 |
_aPiperazines _xtherapeutic use |
| 650 | 0 | 4 |
_aPrecursor B-Cell Lymphoblastic Leukemia-Lymphoma _xdrug therapy |
| 650 | 0 | 4 |
_aPrecursor Cell Lymphoblastic Leukemia-Lymphoma _xdrug therapy |
| 650 | 0 | 4 |
_aPyrimidines _xtherapeutic use |
| 650 | 0 | 4 | _aRemission Induction |
| 650 | 0 | 4 | _aReverse Transcriptase Polymerase Chain Reaction |
| 650 | 0 | 4 | _aTransplantation, Homologous |
| 650 | 0 | 4 |
_aVincristine _xadministration & dosage |
| 700 | 1 | _aBrune, M | |
| 700 | 1 | _aAndersson, P-O | |
| 700 | 1 | _aGustavsson, B | |
| 700 | 1 | _aStockelberg, D | |
| 700 | 1 | _aWadenvik, H | |
| 773 | 0 |
_tBone marrow transplantation _gvol. 30 _gno. 12 _gp. 971-3 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1038/sj.bmt.1703760 _zAvailable from publisher's website |
| 999 |
_c12281058 _d12281058 |
||